BW Communities

Articles for Pharma

DCGI Gives Nod For Restricted Emergency Use Of Russian COVID-19 Vaccine Sputnik V In India: Sources

The approval by the Drugs Controller General of India (DCGI) came after the Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organization (CDSCO) on Monday recommended granting approval to Sputnik V for restricted emergency use subject to certain regulatory conditions.

Read More
Expert Panel Recommends Granting Approval To COVID Vaccine Sputnik V For Emergency Use In India

The Drugs Controller General of India (DCGI) will take a final call on the recommendation. If approved, it will be the third COVID-19 vaccine to be available in India.

Read More
Serum Institute Of India Refunds South Africa For Undelivered COVID-19 Vaccines

A million doses from the institute, which had already been delivered, have been sold on to other countries in the African Union.

Read More
Zydus Cadila Seeks DCGI Nod For Use Of Hepatitis Drug For COVID-19 Treatment

The interim results indicate that the drug when administered early on, could help patients recover faster and avoid much of the complications seen in the advanced stages of the disease

Read More
Vaccine For All Above 45 Years From 1 April: Govt

The union cabinet discussed about the vaccination drive which has already achieved speedy and good progress, Javadekar said.

Read More
Biden Announces All Adult Americans To Be Eligible For COVID-19 Vaccination By May 1

Biden also announced the deployment of more than 4,000 active-duty troops to support vaccination efforts, bringing the total to over 6,000.

Read More
No Export Prohibitions On COVID-19 Vaccines, Says WH

Vaccine manufacturers in the United States are free to export their products while also fulfilling the terms of contracts with the United States.

Read More
Activists, Drug Groups Split Over Suspending COVID-19 Shot Patents

The idea seems simple, but some experts say it's not so clear cut. Below we lay out the reasons.

Read More

Subscribe to our newsletter to get updates on our latest news